Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


22.11.2021

2 Ann Intern Med
9 BMJ
2 Clin Infect Dis
1 Clin Microbiol Rev
1 J Gen Virol
2 J Immunol
5 J Infect Dis
1 J Pediatr
1 J Virol
1 JAMA
10 Lancet
2 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
2 Nat Med
1 PLoS Biol
19 PLoS One
3 Proc Natl Acad Sci U S A
4 Science
28 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. DORFMAN AL, Murthy VL
    Web Exclusive. Annals for Hospitalists Inpatient Notes - Myocarditis After Vaccination for SARS-CoV-2.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed        

  2. CHO BH, Weinbaum C, Tsai Y, Koppaka R, et al
    Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season : A Retrospective Cohort Study.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-1550.
    PubMed         Abstract available


    BMJ

  3. WISE J
    Covid-19: Pfizer vaccine provides 90% protection against infection in children aged 5-11, study finds.
    BMJ. 2021;375:n2746.
    PubMed        

  4. RIMMER A
    Covid vaccination to be mandatory for NHS staff in England from spring 2022.
    BMJ. 2021;375:n2733.
    PubMed        

  5. LOOI MK
    The world according to covid vaccine coverage.
    BMJ. 2021;375:n2732.
    PubMed        

  6. DYER O
    Covid-19: Moderna seeks to exclude US government scientists from vaccine patents, despite public investment.
    BMJ. 2021;375:n2781.
    PubMed        

  7. PATTERSON L
    Encouraging covid vaccine uptake and safe behaviours-an uphill struggle against government complacency.
    BMJ. 2021;375:n2773.
    PubMed        

  8. DYER O
    Covid-19: US doctor who called masks "dangerous" and vaccines a "human experiment" dies of coronavirus.
    BMJ. 2021;375:n2796.
    PubMed        

  9. MAHASE E
    Covid-19: Booster vaccine gives "significant increased protection" in over 50s.
    BMJ. 2021;375:n2814.
    PubMed        

  10. SRIVASTAVA K
    Fake covid vaccines boost the black market for counterfeit medicines.
    BMJ. 2021;375:n2754.
    PubMed        

  11. IACOBUCCI G
    Covid-19: England is preparing to offer annual booster vaccination, says NHS boss.
    BMJ. 2021;375:n2824.
    PubMed        


    Clin Infect Dis

  12. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    PubMed         Abstract available

  13. POLLOCK L, Bennett A, Jere KC, Mandolo J, et al
    Plasma rotavirus-specific IgA and risk of rotavirus vaccine failure in infants in Malawi.
    Clin Infect Dis. 2021 Nov 12. pii: 6426173. doi: 10.1093.
    PubMed         Abstract available


    Clin Microbiol Rev

  14. IYER S, Yadav R, Agarwal S, Tripathi S, et al
    Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases.
    Clin Microbiol Rev. 2021 Nov 17:e0012321. doi: 10.1128/CMR.00123.
    PubMed         Abstract available


    J Gen Virol

  15. WANG C, Lv L, Wu Q, Wang Z, et al
    The role of interferon regulatory factor 7 in the pathogenicity and immunogenicity of rabies virus in a mouse model.
    J Gen Virol. 2021;102.
    PubMed         Abstract available


    J Immunol

  16. SPURRIER MA, Jennings-Gee JE, Daly CA, Haas KM, et al
    The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.
    J Immunol. 2021;207:1978-1989.
    PubMed         Abstract available

  17. HINKLE L, Liu Y, Meng C, Chen Z, et al
    The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived Cells.
    J Immunol. 2021 Nov 12. pii: jimmunol.2100719. doi: 10.4049/jimmunol.2100719.
    PubMed         Abstract available


    J Infect Dis

  18. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
    COVID-19 Vaccination Rates in a Global HIV Cohort.
    J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
    PubMed         Abstract available

  19. COLLIER AY, Yu J, Mcmahan K, Liu J, et al
    COVID-19 mRNA Vaccine Immunogenicity in Immunosuppressed Individuals.
    J Infect Dis. 2021 Nov 18. pii: 6430790. doi: 10.1093.
    PubMed         Abstract available

  20. DUARTE G, Muresan P, Ward S, Laimon L, et al
    Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV.
    J Infect Dis. 2021 Nov 16. pii: 6429421. doi: 10.1093.
    PubMed         Abstract available

  21. ALAM MM, Ikram A, Mahmood N, Sharif S, et al
    Antigenic structure of wild poliovirus type 1 strains endemic in Pakistan is highly conserved and completely neutralized by Sabin's Oral Polio Vaccine.
    J Infect Dis. 2021 Nov 17. pii: 6430438. doi: 10.1093.
    PubMed         Abstract available

  22. BIERLE DM, Ganesh R, Tulledge-Scheitel S, Hanson SN, et al
    Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities.
    J Infect Dis. 2021 Nov 16. pii: 6429422. doi: 10.1093.
    PubMed         Abstract available


    J Pediatr

  23. BERNSTEIN HH, McNally VV, Orenstein WA
    Is It Time For COVID-19 Vaccine Mandates?
    J Pediatr. 2021 Nov 14. pii: S0022-3476(21)01095.
    PubMed        


    J Virol

  24. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    PubMed         Abstract available


    JAMA

  25. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    PubMed        


    Lancet

  26. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    PubMed        

  27. ALIBERTI S, Dela Cruz CS, Amati F, Sotgiu G, et al
    Community-acquired pneumonia.
    Lancet. 2021;398:906-919.
    PubMed         Abstract available

  28. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    PubMed        

  29. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.
    PubMed        

  30. BHUYAN P, Medin J, da Silva HG, Yadavalli M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors' reply.
    Lancet. 2021;398:1801-1802.
    PubMed        

  31. PAVORD S, Scully M, Lester W, Makris M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
    Lancet. 2021;398:1801.
    PubMed        

  32. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    PubMed        

  33. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    PubMed         Abstract available

  34. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    PubMed         Abstract available

  35. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  36. DIXON MG, Ferrari M, Antoni S, Li X, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1563-1569.
    PubMed         Abstract available

  37. NALEWAY AL, Groom HC, Crawford PM, Salas SB, et al
    Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged >/=12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1608-1612.
    PubMed         Abstract available


    N Engl J Med

  38. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    N Engl J Med. 2021;385:e78.
    PubMed        

  39. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
    Decline in Pathogenic Antibodies over Time in VITT.
    N Engl J Med. 2021;385:1815-1816.
    PubMed        


    Nat Med

  40. O'LEARY K
    HPV vaccines beat cervical cancer.
    Nat Med. 2021 Nov 11. pii: 10.1038/d41591-021-00068.
    PubMed        

  41. JUNO JA, Wheatley AK
    Boosting immunity to COVID-19 vaccines.
    Nat Med. 2021 Nov 11. pii: 10.1038/s41591-021-01560.
    PubMed        


    PLoS Biol

  42. KESSIE DK, Rudel T
    Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
    PLoS Biol. 2021;19:e3001462.
    PubMed         Abstract available


    PLoS One

  43. GERRETSEN P, Kim J, Caravaggio F, Quilty L, et al
    Individual determinants of COVID-19 vaccine hesitancy.
    PLoS One. 2021;16:e0258462.
    PubMed         Abstract available

  44. BRESLIN G, Dempster M, Berry E, Cavanagh M, et al
    COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour.
    PLoS One. 2021;16:e0259381.
    PubMed         Abstract available

  45. ISLAM MR, Oraby T, McCombs A, Chowdhury MM, et al
    Evaluation of the United States COVID-19 vaccine allocation strategy.
    PLoS One. 2021;16:e0259700.
    PubMed         Abstract available

  46. BAUM U, Poukka E, Palmu AA, Salo H, et al
    Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.
    PLoS One. 2021;16:e0258704.
    PubMed         Abstract available

  47. VENKATESAN MM, Ballou C, Barnoy S, McNeal M, et al
    Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    PLoS One. 2021;16:e0259361.
    PubMed         Abstract available

  48. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed         Abstract available

  49. KIKUTI M, Sanhueza J, Vilalta C, Paploski IAD, et al
    Porcine reproductive and respiratory syndrome virus 2 (PRRSV-2) genetic diversity and occurrence of wild type and vaccine-like strains in the United States swine industry.
    PLoS One. 2021;16:e0259531.
    PubMed         Abstract available

  50. STOCKELER AM, Schuster P, Zimmermann M, Hanses F, et al
    Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic.
    PLoS One. 2021;16:e0260213.
    PubMed         Abstract available

  51. SCHERRER JF, Salas J, Wiemken TL, Hoft DF, et al
    Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts.
    PLoS One. 2021;16:e0257405.
    PubMed         Abstract available

  52. SCHOMMER SK, Harrison N, Linville M, Samuel MS, et al
    Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance.
    PLoS One. 2021;16:e0260052.
    PubMed         Abstract available

  53. ACEVEDO-VILLANUEVA KY, Renu S, Shanmugasundaram R, Akerele GO, et al
    Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds.
    PLoS One. 2021;16:e0259334.
    PubMed         Abstract available

  54. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed         Abstract available

  55. GOMES LC, Sanson MCG, Brainin P, de Melo MDCV, et al
    Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon.
    PLoS One. 2021;16:e0253752.
    PubMed         Abstract available

  56. RAO CY, Robinson T, Huster K, Laws RL, et al
    Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    PLoS One. 2021;16:e0253108.
    PubMed         Abstract available

  57. COOKSON D, Jolley D, Dempsey RC, Povey R, et al
    A social norms approach intervention to address misperceptions of anti-vaccine conspiracy beliefs amongst UK parents.
    PLoS One. 2021;16:e0258985.
    PubMed         Abstract available

  58. MUHAJARINE N, Adeyinka DA, McCutcheon J, Green KL, et al
    COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    PLoS One. 2021;16:e0259513.
    PubMed         Abstract available

  59. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed         Abstract available

  60. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed         Abstract available

  61. PAPAZOGLOU DD, Baretella O, Feller M, Del Giovane C, et al
    Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    PLoS One. 2021;16:e0260112.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  62. CHU J, Pink SL, Willer R
    Religious identity cues increase vaccination intentions and trust in medical experts among American Christians.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  63. NARR K, Ertuna YI, Fallet B, Cornille K, et al
    Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  64. ADAM D
    News Feature: Biology research, no cells required: By borrowing the machinery of life from broken cells, researchers are producing novel proteins, cheap lab reagents, and just-add-water vaccines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        


    Science

  65. WADMAN M
    To fight Lyme disease, vaccine targets ticks.
    Science. 2021;374:925.
    PubMed         Abstract available

  66. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    PubMed         Abstract available

  67. JECKER NS
    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    PubMed         Abstract available

  68. LADHANI SN
    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    PubMed         Abstract available


    Vaccine

  69. AMEND KL, Turnbull B, Zhou L, Marks MA, et al
    Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01403.
    PubMed         Abstract available

  70. REESE HE, McNamara LA, Vianzon V, Blain A, et al
    Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019.
    Vaccine. 2021 Nov 13. pii: S0264-410X(21)01438.
    PubMed         Abstract available

  71. HARMON SHE, Faour DE, MacDonald NE
    Mandatory immunization and vaccine injury support programs: A survey of 28 GNN countries.
    Vaccine. 2021 Nov 12. pii: S0264-410X(21)01390.
    PubMed         Abstract available

  72. RIBERA-CANO A, Dupont M, Houze-Cerfon CH, Houze-Cerfon V, et al
    Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01429.
    PubMed         Abstract available

  73. WAGNER A, Jasinska J, Tomosel E, Zielinski CC, et al
    Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments.
    Vaccine. 2021 Nov 1. pii: S0264-410X(21)01401.
    PubMed         Abstract available

  74. BURKE RM, Shih S, Hsiung CA, Yen C, et al
    Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children.
    Vaccine. 2021 Nov 14. pii: S0264-410X(21)01397.
    PubMed         Abstract available

  75. CHOKEPHAIBULKIT K, Puthanakit T, Bhat N, Mansouri S, et al
    A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
    Vaccine. 2021 Nov 14. pii: S0264-410X(21)01425.
    PubMed         Abstract available

  76. RODRIGUES CMC, Plotkin SA
    The influence of interval between doses on response to vaccines.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01381.
    PubMed        

  77. CHHABRIA S, Stanford FC
    A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.
    Vaccine. 2021 Nov 11. pii: S0264-410X(21)01442.
    PubMed        

  78. ESPARZA J, Damaso CR
    Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01441.
    PubMed        

  79. BOBO FT, Asante A, Woldie M, Dawson A, et al
    Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01439.
    PubMed         Abstract available

  80. SHARUN K, Tiwari R, Saied AA, Dhama K, et al
    SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01386.
    PubMed         Abstract available

  81. NETANEL C, Ben-Aharon O, Ben-Ari Z, Chodick G, et al
    Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
    Vaccine. 2021 Oct 20. pii: S0264-410X(21)01287.
    PubMed         Abstract available

  82. RADWAN NF, Abu-Sheasha GA, Bedwani RN, Yassine OG, et al
    Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story.
    Vaccine. 2021 Nov 9. pii: S0264-410X(21)01400.
    PubMed         Abstract available

  83. SHAH SFA, Ginossar T, Bentley JM, Zimet G, et al
    Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama.
    Vaccine. 2021 Nov 9. pii: S0264-410X(21)01431.
    PubMed         Abstract available

  84. MALTEZOU HC
    Vaccination of healthcare personnel in the COVID-19 era: A call for actions.
    Vaccine. 2021 Nov 2. pii: S0264-410X(21)01427.
    PubMed        

  85. SVENNERHOLM AM, Qadri F, Lundgren A, Kaim J, et al
    Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
    Vaccine. 2021 Nov 9. pii: S0264-410X(21)01389.
    PubMed         Abstract available

  86. THULUVA S, Matur R, Tsa K, Gv SR, et al
    A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV(TM)) in 1-15 years-old healthy hepatitis A vaccine-naive children.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01326.
    PubMed         Abstract available

  87. KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
    COVID-19 vaccine - Long term immune decline and breakthrough infections.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
    PubMed         Abstract available

  88. HOSANGADI D, Martin EK, Watson M, Bruns R, et al
    Supporting use of thermostable vaccines during public health emergencies: Considerations and recommendations for the future.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01398.
    PubMed        

  89. MCKINNON B, Quach C, Dube E, Tuong Nguyen C, et al
    Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01426.
    PubMed         Abstract available

  90. BABUADZE GG, Echanove J, Lamarre C, deLaVega MA, et al
    A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01315.
    PubMed         Abstract available

  91. GOODE JR, Cook P, Cuttino S, Gatewood SBS, et al
    Early experience with COVID-19 vaccine in a Federally-Qualified Healthcare Center for the homeless.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01388.
    PubMed        

  92. MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
    Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
    PubMed         Abstract available

  93. COLOMBATTI OLIVIERI MA, Moyano RD, Mon ML, Gravisaco MJ, et al
    Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01433.
    PubMed         Abstract available

  94. AW R, Ashik MR, Islam AAZM, Khan I, et al
    Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01432.
    PubMed         Abstract available

  95. JAMES EK, Bokemper SE, Gerber AS, Omer SB, et al
    Persuasive messaging to increase COVID-19 vaccine uptake intentions.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01368.
    PubMed         Abstract available

  96. CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
    Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
    Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
    PubMed         Abstract available


    Virus Res

  97. XIAO T, Leng H, Zhang Q, Chen Q, et al
    Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.
    Virus Res. 2021 Nov 15:198633. doi: 10.1016/j.virusres.2021.198633.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: